SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: New York Mortgage Trust, Inc. (Note: Metadata referenced "ADAMAS TRUST, INC." but the filing text identifies the registrant as New York Mortgage Trust, Inc.)
Filing Date: November 26, 2014
Event Date: November 21, 2014
Context: The Company entered into a material definitive agreement to conduct a public offering of common stock.
Key Financial Metrics
This filing reports on a capital raising event rather than operational performance metrics. Key figures include:
- Shares Sold: 14,410,019 shares of Common Stock (13,000,000 base offering + 1,410,019 from partial option exercise).
- Net Proceeds: Approximately $110.8 million (after underwriting discounts, commissions, and estimated offering expenses).
- Underwriters: UBS Securities LLC, Deutsche Bank Securities Inc., Barclays Capital Inc., RBC Capital Markets, LLC, and Credit Suisse Securities (USA) LLC.
Revenue, profit, cash flow, margins, debt, and liquidity metrics are not provided in this specific filing.
Material Changes
The primary material change is the increase in the Company's equity capital and share count resulting from the closing of the offering on November 26, 2014. The Company utilized a shelf registration statement (Form S-3, File No. 333-198177) effective August 15, 2014, to facilitate this issuance.
Outlook, Risks, and Contingencies
Management Commentary: The filing confirms the successful closing of the offering and the partial exercise of the underwriters' 30-day option to purchase additional shares.
Risks and Contingencies:
- The Underwriting Agreement includes customary indemnification provisions where the Company agreed to indemnify Underwriters against certain liabilities under the Securities Act of 1933.
- Future conflicts of interest may arise as Underwriters or their affiliates may engage in various financing, commercial banking, and investment banking services with the Company.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-offering to assess dilution impact.
- Confirm the specific use of the $110.8 million in net proceeds (e.g., debt repayment, asset acquisition, or general corporate purposes) in subsequent filings.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants or lock-up periods.
- Check for any subsequent filings regarding the remaining unexercised portion of the 30-day option (up to 539,981 shares).